Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function.
about
Disruption of the Toxoplasma gondii parasitophorous vacuole by IFNgamma-inducible immunity-related GTPases (IRG proteins) triggers necrotic cell deathTpl2 kinase regulates T cell interferon-gamma production and host resistance to Toxoplasma gondiiThe polymorphic pseudokinase ROP5 controls virulence in Toxoplasma gondii by regulating the active kinase ROP18MIF Promotes Classical Activation and Conversion of Inflammatory Ly6C(high) Monocytes into TipDCs during Murine Toxoplasmosis.Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinaseInactivation of LRG-47 and IRG-47 reveals a family of interferon gamma-inducible genes with essential, pathogen-specific roles in resistance to infectionThe myeloid receptor PILRβ mediates the balance of inflammatory responses through regulation of IL-27 productionToxoplasma gondii upregulates interleukin-12 to prevent Plasmodium berghei-induced experimental cerebral malaria.Dynamics of T cell, antigen-presenting cell, and pathogen interactions during recall responses in the lymph nodeInterleukin-10 plays an early role in generating virus-specific T cell anergy.Transforming growth factor beta1 is expressed in the jejunum after experimental Cryptosporidium parvum infection in humans.The unexpected role for the aryl hydrocarbon receptor on susceptibility to experimental toxoplasmosisThe role of DNA microarrays in Toxoplasma gondii research, the causative agent of ocular toxoplasmosis.Development of Neurological Mouse Model for Toxoplasmosis Using Toxoplasma gondii Isolated from Chicken in Kenya.Localized multigene expression patterns support an evolving Th1/Th2-like paradigm in response to infections with Toxoplasma gondii and Ascaris suum.In vitro investigation of host resistance to Toxoplasma gondii infection in microglia of BALB/c and CBA/Ca miceThe extracellular matrix protein mindin as a novel adjuvant elicits stronger immune responses for rBAG1, rSRS4 and rSRS9 antigens of Toxoplasma gondii in BALB/c miceMonocyte-mediated defense against microbial pathogens.Mechanism of entry determines the ability of Toxoplasma gondii to inhibit macrophage proinflammatory cytokine productionThe function of gamma interferon-inducible GTP-binding protein IGTP in host resistance to Toxoplasma gondii is Stat1 dependent and requires expression in both hematopoietic and nonhematopoietic cellular compartmentsThe protozoan Neospora caninum directly triggers bovine NK cells to produce gamma interferon and to kill infected fibroblastsFoxp4 is dispensable for T cell development, but required for robust recall responsesA GRA1 DNA vaccine primes cytolytic CD8(+) T cells to control acute Toxoplasma gondii infectionLack of IL-15 results in the suboptimal priming of CD4+ T cell response against an intracellular parasite.Proprotein convertase FURIN constrains Th2 differentiation and is critical for host resistance against Toxoplasma gondii.Toxoplasma gondii inhibits toll-like receptor 4 ligand-induced mobilization of intracellular tumor necrosis factor alpha to the surface of mouse peritoneal neutrophils.The immunology of parasite infections in immunocompromised hosts.CD8 T Cells and Toxoplasma gondii: A New ParadigmIn the belly of the beast: subversion of macrophage proinflammatory signalling cascades during Toxoplasma gondii infection.Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunityATF6beta is a host cellular target of the Toxoplasma gondii virulence factor ROP18.Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes.Turning it on and off: regulation of dendritic cell function in Toxoplasma gondii infection.Manipulation of mitogen-activated protein kinase/nuclear factor-kappaB-signaling cascades during intracellular Toxoplasma gondii infection.The role of type I interferons in non-viral infections.Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma gondii.The secreted kinase ROP18 defends Toxoplasma's border.Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAPParasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infectionRecruitment of Gr-1+ monocytes is essential for control of acute toxoplasmosis
P2860
Q21559499-E23036ED-87D9-4FA2-9640-8B69E9654562Q24655428-1572136E-BB3B-42E7-B178-CA559709BBC9Q27341809-8B808DC2-247D-42AF-A7A1-A591AD10B168Q27348931-6BCD04A2-5F4B-4629-AD2D-4A17812BD552Q28392677-12547C9E-3607-45AC-BADC-3E9AE39CC71AQ28586576-D6D87ECC-BC51-448E-AFB4-1010EE0A855CQ28730911-F1671DCF-FA5D-4D4B-96F9-241B39CCCAB2Q30411019-BAB6AD23-4A63-43CD-90AC-0D31905452D7Q30541235-45CC08F3-A97C-4521-9B2A-DA1C2E05E057Q33287802-744C82E8-C6CD-48A7-8D91-83929B97B9F1Q33600405-8A0E71E7-3342-4E0D-B294-BE07DCAFCBCEQ33606707-7631501F-00C5-4895-88E8-62E0F68F73ACQ33631447-6FE36579-45A5-4044-8718-3720A92BC0CDQ33775618-7BF8CA73-A4A3-4E9F-A037-121D902F1051Q33792618-11F7E34D-8B37-40D8-A6B4-047B810C8A51Q34005898-0744A015-6F0B-4900-84BB-5A04105FBB08Q34037687-79BA83EB-4F32-45BA-ABB6-10FB3409C14AQ34065898-0142A98D-E448-4A05-948D-D72B31C0D485Q34130856-A0FB592A-4C24-4A57-8D22-A6A65E5A982DQ34257220-00F3A4D0-8CE6-4A40-A7CF-EDCC679685E1Q34334173-7B5CCDFE-4DD6-46C0-887C-7E58DCAE30B3Q34388716-8869CC84-FAF3-4805-9394-8BA60B5C6FF5Q34525371-06161BD7-8903-4663-A707-2C557FD480FBQ34597905-C7C4C4EB-984C-46F1-A11C-0F0B3F2FCFADQ34669530-327424CC-86A6-4401-8775-9D5E4D0D6410Q34721141-8CCBCB79-AC31-4C41-8C0B-F29B01EDE530Q35029729-7D4236D6-22BA-4FCD-99E9-A77CE5D5EB41Q35038836-F3581128-A113-4CC2-A9B9-274217018A5EQ35064310-2A39D807-248D-49B1-8B32-13629EE9317FQ35088408-81EBF135-E621-4D60-839B-E03269D65D55Q35102296-8DE9B34D-2559-4786-ADE7-BDDA55BECF85Q35139747-69E75D11-2F17-4C4E-8DC6-C240DADE283DQ35884184-1E3EAF2A-11E4-4CD7-8D63-8C204CDCD598Q35884234-EE0A9E1B-86E9-440D-89DF-247262FE4AC9Q35951793-293958BE-625A-45E6-8C8C-7FFB0B503344Q36015869-F18EDA46-1356-486E-8D69-DFD124B50A52Q36041799-C153D032-D56C-4F25-A289-7D7898D9CBFBQ36310561-EAE4DBFD-05C6-41C0-B5AD-AE1A149E104FQ36371418-9E129A29-93EE-4796-BA3F-C1B679FC1113Q36403789-2DF749B2-AE84-405E-BB55-28647FA7F92B
P2860
Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Cell-mediated immunity to Toxo ...... ulation and effector function.
@ast
Cell-mediated immunity to Toxo ...... ulation and effector function.
@en
type
label
Cell-mediated immunity to Toxo ...... ulation and effector function.
@ast
Cell-mediated immunity to Toxo ...... ulation and effector function.
@en
prefLabel
Cell-mediated immunity to Toxo ...... ulation and effector function.
@ast
Cell-mediated immunity to Toxo ...... ulation and effector function.
@en
P1433
P1476
Cell-mediated immunity to Toxo ...... ulation and effector function.
@en
P304
P356
10.1016/S0171-2985(99)80064-3
P577
1999-12-01T00:00:00Z